$SUNPHARMA reported its audited financial results for the quarter and year ended March 31, 2026, with FY26 revenue rising 11.9% to Rs. 582,201 million and net profit increasing 5.0% to Rs. 114,794 million. The Board recommended a final dividend of Rs. 5.00 per share, bringing the total dividend for the year to Rs. 16.00 per share. Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations.